Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the effect of semaglutide s.c. 1.0 mg once-weekly versus placebo as add-on to sodiumglucose co-transporter-2 inhibitor monotherapy or in combination with either metformin or sulfonylurea on glycaemic control after 30 weeks of treatment in subjects with type 2 diabetes.
Critère d'inclusion
- Diabetes Mellitus, Type 2